21/12/2018

Giovannelli e Associati advised Altheia Science on a capital increase of its corporate capital

Giovannelli e Associati advised Altheia Science, a biotech start-up incorporated to develop curative medicine for autoimmune diseases (multiple sclerosis and diabetes) on the capital increase of its corporate capital.  The […]
28/11/2018

Giovannelli e Associati advised Ardian on the acquisition of a majority stake of Neopharmed Gentili Group

Giovannelli e Associati advised the French private equity fund Ardian on the acquisition of a majority stake of Neopharmerd Gentili group, a pharmaceutical company, from Mediolanum Farmaceutici. The team of […]
26/09/2018

Giovannelli e Associati advised Imecon Engineering S.r.l.’s quotaholders on the sale of the majority stake to Cifin S.r.l.

Giovannelli e Associati advised Imecon Engineering S.r.l.’s quotaholders on the sale of the majority stake to Cifin S.r.l., now Voilàp Holding. Imecon Engineering S.r.l. is a leading Italian company that […]